AllianceBernstein
MNOV icon

AllianceBernstein’s MediciNova MNOV Stock Holding History

AllianceBernstein’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31,300
Closed -$158K – 3377
2021
Q1 		$158K Hold
31,300
– – ﹤0.01% 3102
2020
Q4 		$165K Sell
31,300
-5,500
-15% -$31.5K ﹤0.01% 3035
2020
Q3 		$193K Hold
36,800
– – ﹤0.01% 2964
2020
Q2 		$199K Buy
36,800
+7,700
+26% +$40.8K ﹤0.01% 3007
2020
Q1 		$108K Buy
29,100
+1,900
+7% +$9.89K ﹤0.01% 2944
2019
Q4 		$183K Hold
27,200
– – ﹤0.01% 2942
2019
Q3 		$216K Buy
27,200
+4,600
+20% +$41K ﹤0.01% 2917
2019
Q2 		$218K Buy
22,600
+3,200
+16% +$33.7K ﹤0.01% 2936
2019
Q1 		$161K Buy
19,400
+4,600
+31% +$40.1K ﹤0.01% 2948
2018
Q4 		$121K Buy
14,800
+4,200
+40% +$41.9K ﹤0.01% 2972
2018
Q3 		$132K Buy
+10,600
New +$106K ﹤0.01% 3053

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein's MNOV Position: Q2 2021 in Review

AllianceBernstein sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 31,300 shares — an estimated $158K sold.

AllianceBernstein first reported a position in MNOV in Q3 2018 and held it in 11 quarters. The position peaked at $218K in Q2 2019. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

  • AllianceBernstein reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 31,300 MediciNova shares in Q2 2021, an estimated $158K.
  • AllianceBernstein first reported a position in MediciNova in Q3 2018 and held it in 11 quarters.
  • AllianceBernstein's MediciNova position peaked at $218K in Q2 2019.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.